Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy - Concepedia

Concepedia

Publication | Closed Access

Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy

120

Citations

25

References

2007

Year

Yoshitsugu Mitani, Naohide Oue, Satoko Matsumura, Kazuhiro Yoshida, T Noguchi, Masaoki Ito, Shoma Tanaka, Hiroki Kuniyasu, Nobuyuki Kamata, W Yasui

Prognostic BiomarkersReg IvMedicineGastroenterologyPathologyGastric Cancer PatientsCancer TreatmentOncologyRadiation OncologySerum BiomarkerCancer Research

References

	Year	Citations

Page 1

Page 1